Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCT-01 in Chronic Achilles Tendinosis
NCT02330146Phase 2Terminated
- Sponsor
- RepliCel Life Sciences Inc.
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of RCT-01 in Achilles tendinosis (AT), sponsored by RepliCel Life Sciences Inc.. Started May 2015; status: terminated.
02
Drugs
RCT-01
03
Conditions
Achilles tendinosis (AT)
Beyond the preview
Go deeper on NCT02330146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330146.